Speakers

Dr. Alex J. Krotulski serves as the Director of Toxicology and Chemistry at the Center for Forensic Science Research and Education (CFSRE) in the United States. Dr. Krotulski is the Program Manager for NPS Discovery, the CFSRE’s open-access drug early warning system. Dr. Krotulski is a chemist by training and has practiced as a forensic toxicologist for ten years. Dr. Krotulski holds faculty appointment and serves as the forensic toxicology Program Director for Thomas Jefferson (Philadelphia, PA) and is a Senior Associate Editor for the Journal of Analytical Toxicology. Dr. Krotulski serves on both the SOFT and TIAFT NPS Committees, among other committees and working groups across forensic fields.<br /><br />Dr. Krotulski received his PhD in Chemistry from Temple University (Philadelphia, PA) in 2019, his MS in Forensic Science from Arcadia University (Glenside, PA) in 2015, and his BS in Chemistry from Loyola University New Orleans (New Orleans, LA) in 2013. To date, Dr. Krotulski has authored or co-authored more than 80 peer-reviewed journal publications in the areas of forensic toxicology, clinical toxicology, and forensic chemistry, in addition to giving more than 140 scientific presentations across various areas of forensic science, mass spectrometry, and analytical chemistry.

Dr Helen Wihongi (ia). Te Aitanga a Hauiti, Te Whanau a Āpanui, Ngāti Porou and Ngāpuhi descent. She is the National Māori Health Research Lead for Te Whatu Ora. She works with the Evidence Research and Clinical Trials Team to establish a national research and clinical trials infrastructure aiming to support regional research and clinical trial endeavours. As a community psychologist she endeavours to critique systems and implement improvement strategies that include Te Tiriti o Waitangi, tikanga (Māori beliefs and values) and Māori and Western scientific mātauranga (Māori and Western scientific knowledge).<br /><br />Helen’s research interests are mātauranga and tikanga Maori, particularly as they relate to Māori health and wellbeing. She is currently a co-lead in the establishment of a genomics tertiary pathway along with Professor Cris Print, a project funded by Ministry of Business Innovation and Employment. She is also part of a team looking at Rongoa Māori in clinical service delivery.

I work as a professor in psychopharmacology at Maastricht University in the Netherlands. My research combines methods from psychopharmacology, forensic toxicology and cognitive neuroscience to determine drug induced changes in human performance. In my work, I focus on the impact of different substances of (ab)use, including cannabis, stimulants, opioids, novel psychoactive substances (NPS) and psychedelics on neuronal networks and human cognition. This work bears relevance in the context of drug development and therapeutics and in legal settings when evaluating the impact of drug exposure on human function.<br /><br /><a href="https://www.pimaastricht.com/scientists/2-jan-ramaekers" target="_blank" rel="noopener noreferrer">Full Bio</a>